A pharmaceutical company focused on the new drug platform for transdermal patches and the research and development of related drugs.
Ruifulai Pharma has a new drug platform for transdermal patches.
T-Capital focuses on the technical capabilities, product value, and industrialization development opportunities of platform-based drug R&D companies.
Note: Specific transaction information is subject to public disclosure and project authorization information.
This page describes a representative transaction T-Capital has been involved in. Specific transaction details, amounts, and other terms are subject to public disclosures and authorized information from the parties involved.
If you are considering financing, M&A, divestiture, licensing & business development, or a strategic partnership, we invite you to discuss your project with the T-Capital team.
Contact Us →